Found: 4
Select item for more details and to access through your institution.
FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.
- Published in:
- Oncologist, 2021, v. 26, n. 1, p. e164, doi. 10.1002/onco.13551
- By:
- Publication type:
- Article
Luminal A Breast Cancer and Molecular Assays: A Review.
- Published in:
- Oncologist, 2018, v. 23, n. 5, p. 556, doi. 10.1634/theoncologist.2017-0535
- By:
- Publication type:
- Article
HALT-D: A Phase II Evaluation of Crofelemer for the Prevention and Prophylaxis of Diarrhea in Patients With Breast Cancer on Pertuzumab-Based Regimens.
- Published in:
- 2017
- By:
- Publication type:
- journal article
FDA Oncology Center of Excellence Review Processes and Tools.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 108, n. 3, p. 428, doi. 10.1002/cpt.1945
- By:
- Publication type:
- Article